0001595722-20-000005.txt : 20200528 0001595722-20-000005.hdr.sgml : 20200528 20200528165339 ACCESSION NUMBER: 0001595722-20-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200528 DATE AS OF CHANGE: 20200528 EFFECTIVENESS DATE: 20200528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Artio Medical, Inc. CENTRAL INDEX KEY: 0001595722 IRS NUMBER: 434342007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367869 FILM NUMBER: 20921985 BUSINESS ADDRESS: STREET 1: 10900 S. CLAY BLAIR BLVD., SUITE 200 CITY: OLATHE STATE: KS ZIP: 66061 BUSINESS PHONE: 913 440 4439 MAIL ADDRESS: STREET 1: 10900 S. CLAY BLAIR BLVD., SUITE 200 CITY: OLATHE STATE: KS ZIP: 66061 FORMER COMPANY: FORMER CONFORMED NAME: Metactive Medical, LLC DATE OF NAME CHANGE: 20140102 D 1 primary_doc.xml X0708 D LIVE 0001595722 Artio Medical, Inc. 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 913 440 4439 DELAWARE Metactive Medical, Inc. Metactive Medical, LLC Corporation true Frank Nicholas Franano 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Executive Officer Director Nathaniel Hagedorn 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Director Jenny Martin 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Executive Officer James M. Schultz 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Director Maria Sainz 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Director Jeff Weinrich 4220 Shawnee Mission Parkway Suite B350 Fairway KS KANSAS 66205 Director Biotechnology Decline to Disclose 06b false true false true true true The offering is made in connection with a proposed stock-for-stock merger transaction.If the merger transaction is completed, Issuer will issue securities to the acquired company's equityholders at closing based on a negotiated conversion ratio. 0 17073891 0 17073891 Management estimate prior to consummation of the proposed stock-for-stock merger transaction. Final aggregate value of securities ultimately issued as non-cash merger consideration may vary from this estimate. false 0 0 0 0 No cash proceeds will be received by the Issuer in connection with the offering. false Artio Medical, Inc. /s/Frank Nicholas Franano Frank Nicholas Franano President/CEO/Director 2020-05-28